Archives: Speakers

Dr. Grace Farhat is an expert in the role of nutrition, antioxidants, and herbal extracts on health, particularly in the context of ageing. With a BSc in Nutrition and Dietetics, an MSc in Human Nutrition, and a PhD focused on the effects of antioxidants on health markers in older adults, she brings a wealth of scientific knowledge to her research. Her current work explores the impact of pomegranate extract, specifically Pomanox, on inflammatory markers, cardiometabolic health, and cognitive function in older adults. Dr. Farhat’s research provides compelling evidence for the efficacy of pomegranate as a natural intervention for improving health outcomes in ageing populations. She has authored numerous peer-reviewed publications on the therapeutic effects of pomegranate, polyphenols, and antioxidants in managing chronic conditions such as obesity, inflammation, and cognitive decline. As both a UK Registered Nutritionist (Rnutr) and Registered Dietitian (RD), Dr. Farhat is well-versed in the practical applications of nutrition in addressing health challenges for older adults.

Andrea Zangara holds a BSc in Clinical Psychology from the University of Padua and an MSc in Clinical Phytotherapy from the University of Barcelona. With over 20 years of experience in pharmaceutical and nutraceutical R&D, he has held executive positions in academia and industry. Since 2017, he has led Scientific Marketing & Medical Affairs at Euromed S.A. Andrea specializes in scientific marketing of herbal extracts, translating clinical data into product strategies for global markets, and advancing plant-based health solutions.

Ana is a pharmacist, with a master’s degree in clinical trials, pharma economics and business executive. She started her career more than 20 years ago, as a CRA, passing through different positions of higher responsibility at Novartis and GSK. He joined Insud  Pharma 4 years ago and is responsible for the execution and strategy of all trials globally, from phase I to IV, trying to implement with maximum creativity in a highly legislated world. To this end, Insud has incorporated AI in all phases of the life of the study, improving time and quality.

Fiona chairs the Sustainable Healthcare Coalition that inspires partnerships and action on sustainable healthcare. She also works as an independent expert advisor and board member for national and global organisations on wellbeing and sustainability.

She is a high-profile wellbeing and public health leader with a track record of reframing thinking and developing innovative strategy and programmes at the heart of business and government. Her previous roles include Deputy Chief Medical Officer and Director General in the UK Government, Director of Chronic Disease and Health Promotion at the World Health Organisation and Bupa’s Chief Wellbeing Officer.

Fiona is a visiting Professor at UCL and is a Senior Associate at Cambridge Institute for Sustainability Leadership.  Fiona’s recent board roles include Fresenius ESG Advisory Board, My Green Lab, British Land’s Sustainability Advisory Panel, Marks and Spencer’s Sustainable Retail Advisory Board, and Business in the Community’s Wellbeing Leadership Team. Fiona is a member of the Health System Taskforce of the Sustainable Markets Initiative.

With over 40 years of experience in the clinical research industry, I’ve had the privilege of working in large pharma, biotech, and CRO environments. I began my career as a Clinical Research Associate and have since held a broad range of leadership, operational, and commercial roles, gaining extensive global experience in clinical development, business development, outsourcing, and contracting.

 My therapeutic expertise spans multiple areas including CNS, cardiovascular, ophthalmology and hepatology, with a strong focus over the past decade on the development of advanced therapy medicinal products (ATMPs), particularly cell and gene therapies.

 I am currently the Vice President of Clinical Operations at Resolution Therapeutics Limited, a pioneering UK-based biotechnology company developing regenerative macrophage cell therapies. I remain deeply passionate about clinical research, am a committed advocate of the UK biotech sector, and am firmly driven by the mission to help bring innovative medicines to patients worldwide.